After Failure With Acenocoumarol, Rivaroxaban in Antiphospholipid Syndrome: A Report of 2 Cases

Volume: 15, Issue: 5, Pages: e33 - e35
Published: Sep 1, 2019
Abstract
Antiphospholipid syndrome is characterised by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol. El síndrome antifosfolipídico se caracteriza por abortos o fenómenos trombóticos asociado a anticuerpos específicos. El tratamiento se basa en la...
Paper Details
Title
After Failure With Acenocoumarol, Rivaroxaban in Antiphospholipid Syndrome: A Report of 2 Cases
Published Date
Sep 1, 2019
Volume
15
Issue
5
Pages
e33 - e35
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.